Phase
Condition
Knee Injuries
Osteoarthritis
Treatment
Magnesium Threonate
Control
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients undergoing primary total knee or hip arthroplasty at the University ofMiami Hospital
Patients > 18 years of age
Subjects must be capable of providing informed consent
English or Spanish-speaking
Exclusion
Exclusion Criteria:
Previous total joint arthroplasty at the surgical site
History of sleeping disorders, including narcolepsy, sleep apnea, insomnia,parasomnias, and restless leg syndrome.
History of Complex Regional Pain Syndrome in ipsilateral extremity
History of demyelinating disorder or neurologic deficit in the affected extremity
History of psychiatric disorders that could impact sleep, such as untreateddepression, bipolar disorder, or schizophrenia.
Participants taking medications known to cause significant sedation or insomnia.
Pregnant or breastfeeding
Being treated for a diagnosis other than primary osteoarthritis (e.g. pelvic/femurfracture)
Patients with known substance use disorder within 6 months of surgery
Liver Failure, via clinical diagnosis or international normalized ratio greater than 1.5 or Prothrombin time greater than 40
Chronic Kidney Disease or glomerular filtration rate less than 30 mL/min
Study Design
Connect with a study center
University of Miami Hospital
Miami, Florida 33136
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.